Double-blind study of the analgesic effect of ethoheptazine-aspirin.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000704:Analysis of Variance; D001241:Aspirin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001381:Azepines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003864:Depression, Chemical; D004341:Drug Evaluation; D004342:Drug Hypersensitivity; D004359:Drug Therapy, Combination; D005260:Female; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006261:Headache / Q000139:chemically induced; D006801:Humans; D008297:Male; D008875:Middle Aged; D010146:Pain / Q000188:drug therapy* / Q000209:etiology; D010149:Postoperative Pain / Q000188:drug therapy*; D010919:Placebos; D012877:Skin Manifestations; D013268:Stimulation, Chemical; D013997:Time Factors; D014786:Vision Disorders / Q000139:chemically induced; D014947:Wounds and Injuries / Q000150:complications
D001381:Azepines; D010919:Placebos; D001241:Aspirin